Skip to main content

Palliative Care in Hematopoietic Stem Cell Transplantation

  • Chapter
  • First Online:
Palliative Care in Pediatric Oncology

Part of the book series: Pediatric Oncology ((PEDIATRICO))

  • 1386 Accesses

Abstract

Hematopoietic stem cell transplantation (HSCT) offers a potentially curative treatment for children with advanced hematologic and some non-hematologic malignancies. Since the risk for severe toxicity, treatment-related death, or significant long-term sequelae still substantially exceeds the risks of conventional cancer therapy, HSCT is only considered after relapse or in high-risk cases. Pediatric HSCT patients and their families often face a high burden of symptoms and suffering throughout the immediate course of the transplant and sometimes for years thereafter. Palliative care can introduce aspects of quality of life into the transplant procedure to reduce suffering and support families to cope with long-term sequelae and therapy failure. Specialized pediatric palliative care services could provide much needed additional support during the inpatient phase of the transplant, bridge the gap to the home care setting, assist in care coordination, and take care of the physical, emotional, and spiritual suffering of the patient and the family. Furthermore, palliative care counseling may be helpful in facilitating goals-of-care discussions and advance care planning before HSCT and during the posttransplant phase. Although therapy-related mortality has considerably decreased in the last two decades, a significant number of pediatric HSCT recipients still die due to relapse, acute treatment-related complications, or progressing chronic conditions. In these children, integration of pediatric palliative care can facilitate end-of-life communication and reduce unwarranted interventions such as intubation or cardiopulmonary resuscitation close to the end of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Armenian SH, Sun C-L, Kawashima T et al (2011) Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood 118(5):1413–1420. https://doi.org/10.1182/blood-2011-01-331835

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bader P, Kreyenberg H, von Stackelberg A et al (2015) Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial. J Clin Oncol 33(11):1275–1284. https://doi.org/10.1200/JCO.2014.58.4631

    Article  CAS  PubMed  Google Scholar 

  • Bitan M, He W, Zhang MJ et al (2014) Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens. Blood 123(10):1615–1620. https://doi.org/10.1182/blood-2013-10-535716

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bomken S, Skinner R (2015) Secondary malignant neoplasms following haematopoietic stem cell transplantation in childhood. Children 2:146–173. https://doi.org/10.3390/children2020146

    Article  PubMed  PubMed Central  Google Scholar 

  • Bradshaw G, Hinds PS, Lensing S, Gattuso JS, Razzouk BI (2005) Cancer-related deaths in children and adolescents. J Palliat Med 8(1):86–95. https://doi.org/10.1089/jpm.2005.8.86

    Article  PubMed  Google Scholar 

  • Caruso Brown AE, Cohen MN, Tong S et al (2015) Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients. Antimicrob Agents Chemother 59(7):3718–3725. https://doi.org/10.1128/AAC.04348-14

    Article  PubMed  PubMed Central  Google Scholar 

  • Choi DK, Helenowski I, Hijiya N (2014) Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature. Int J Cancer 135(8):1764–1773

    Google Scholar 

  • Chow EJ, Anderson L, Baker KS et al (2016) Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a children’s oncology group report. Blood Marrow Transplant 22(5):7827–7895. https://doi.org/10.1016/j.bbmt.2016.01.023

    Google Scholar 

  • Cohen J, Cooper N, Chakrabarti S et al (2007) EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning. Leuk Lymphoma 48:256–269. https://doi.org/10.1080/10428190601059837

    Article  PubMed  Google Scholar 

  • Collins JJ, Geake J, Grier HE (1996) Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone. J Pediatr 129(5):722–728

    Article  CAS  PubMed  Google Scholar 

  • Conter V, Valsecchi MG, Parasole R et al (2014) Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study. Blood 123(10):1470–1478. https://doi.org/10.1182/blood-2013-10-532598

    Article  CAS  PubMed  Google Scholar 

  • Danner-Koptik KE, Majhail NS, Brazauskas R et al (2013) Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant 48(3):363–368. https://doi.org/10.1038/bmt.2012.166

    Article  CAS  PubMed  Google Scholar 

  • Deeg HJ, Socié G, Schoch G et al (1996) Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 87(1):386–392

    CAS  PubMed  Google Scholar 

  • Didsbury MS, Mackie FE, Kennedy SE (2015) A systematic review of acute kidney injury in pediatric allogeneic hematopoietic stem cell recipients. Pediatr Transplant 19(5):460–470. https://doi.org/10.1111/petr.12483

    Article  PubMed  Google Scholar 

  • Dietrich-Ntoukas T, Cursiefen C, Westekemper H et al (2012) Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the Germn-Austrian-Swiss consensus conference on clinical practice in chronic GVHD. Cornea 31(3):299–310

    Article  PubMed  Google Scholar 

  • El-Jawahri A, LeBlanc T, Van Dusen H et al (2016) Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA 316(20):2094–2103. https://doi.org/10.1001/jama.2016.16786

    Article  PubMed  PubMed Central  Google Scholar 

  • Federmann B, Hägele M, Pfeiffer M et al (2011) Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted grafts. Leukemia 25(1):121–129. https://doi.org/10.1038/leu.2010.235

    Article  CAS  PubMed  Google Scholar 

  • Fernández-García M, Gonzalez-Vicent M, Mastro-Martinez I et al (2015) Intensive care unit admissions among children after hematopoietic stem cell transplantation: incidence, outcome, and prognostic factors. J Pediatr Hematol Oncol 37(7):529–535. https://doi.org/10.1097/MPH.0000000000000401

    Article  PubMed  Google Scholar 

  • Feudtner C, Womer J, Augustin R et al (2013) Pediatric palliative care programs in children's hospitals: a cross-sectional national survey. Pediatrics 132(6):1063–1070. https://doi.org/10.1542/peds.2013-1286

    Article  PubMed  Google Scholar 

  • Fiuza-Luces C, Garatachea N, Simpson RJ et al (2015) Understanding graft-versus-host disease. Preliminary findings regarding the effects of exercise in affected patients. Exerc Immunol Rev 21:80–112

    PubMed  Google Scholar 

  • Forinder U, Norberg AL (2014) Posttraumatic growth and support among parents whose children have survived stem cell transplantation. J Child Health Care 18(4):326–335. https://doi.org/10.1177/1367493513496666

    Article  PubMed  Google Scholar 

  • Gale RP, Horowitz MM, Ash RC et al (1994) Identical twin bone marrow transplants for leukemia. Ann Intern Med 120:646–652

    Article  CAS  PubMed  Google Scholar 

  • Groh G, Borasio GD, Nickolay C et al (2013) Specialized pediatric palliative home care: a prospective evaluation. J Palliat Med 16(12):1588–1594. https://doi.org/10.1089/jpm.2013.0129

    Article  PubMed  PubMed Central  Google Scholar 

  • Gurney JG, Ness KK, Rosenthal J et al (2006) Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the bone marrow transplant survivor study. Cancer 106(6):1402–1408

    Article  PubMed  Google Scholar 

  • Hildebrandt GC, Fazekas T, Lawitschka A et al (2011) Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant 46:1283–1295

    Article  CAS  PubMed  Google Scholar 

  • Hutt D, Nehari M, Munitz-Shenkar D et al (2015) Hematopoietic stem cell donation: psychological perspectives of pediatric sibling donors and their parents. Bone Marrow Transplant 50:1337–1342

    Article  CAS  PubMed  Google Scholar 

  • Jobe-Shields L, Alderfer MA, Barrera M et al (2009) Parental depression and family environment predict distress in children before stem cell transplantation. J Dev Behav Pediatr 30(2):140–146. https://doi.org/10.1097/DBP.0b013e3181976a59

    Article  PubMed  PubMed Central  Google Scholar 

  • Kazak AE, Simms S, Alderfer MA et al (2005) Feasibility and preliminary outcomes from a pilot study of a brief psychological intervention for families of children newly diagnosed with cancer. J Pediatr Psychol 30:644–655

    Article  PubMed  Google Scholar 

  • Kazak AE, Rourke MT, Alderfer MA et al (2007) Evidenced-based assessment, intervention, and psychosocial care in pediatric oncology: a blueprint for comprehensive services across treatment. J Pediatr Psychol 32:1099–1110

    Article  PubMed  Google Scholar 

  • Kolb HJ, Mittermüller J, Clemm C et al (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462–2465

    CAS  PubMed  Google Scholar 

  • Lafond DA, Kelly KP, Hinds PS, Sill A, Michael M (2015) Establishing feasibility of early palliative care consultation in pediatric hematopoietic stem cell transplantation. J Pediatr Oncol Nurs 32(5):265–277. https://doi.org/10.1177/1043454214563411

    Article  PubMed  Google Scholar 

  • Lawitschka A, Güclü ED, Varni JW et al (2014) Health-related quality of life in pediatric patients after allogeneic SCT: development of the PedsQL stem cell transplant module and results of a pilot study. Bone Marrow Transplant 49:1093–1097

    Article  CAS  PubMed  Google Scholar 

  • Lee SJ (2017) Classification systems for chronic graft-versus-host disease. Blood 129(1):30–37

    Google Scholar 

  • Lee KH, Lee JH, Lee JH et al (2011) Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome. Blood 118(9):2609–2617. https://doi.org/10.1182/blood-2011-02-339838

    Article  CAS  PubMed  Google Scholar 

  • Lee SJ, Wolff D, Kitko C (2015) Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group Report. Biol Blood Marrow Transplant 21:984–999

    Article  PubMed  PubMed Central  Google Scholar 

  • Llaurador G, McLaughlin L, Wistinghausen B (2016) Management of post-transplant lymphoproliferative disorders. Curr Opin Pediatr 29(1):34–40

    Google Scholar 

  • Loggers ET, Lee S, Chilson K et al (2014) Advance care planning among hematopoietic cell transplant patients and bereaved caregivers. Bone Marrow Transplant 49(10):1317–1322. https://doi.org/10.1038/bmt.2014.152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lotz JD, Daxer M, Jox RJ, Borasio GD, Führer M (2017) “Hope for the best, prepare for the worst”: A qualitative interview study on parents’ needs and fears in pediatric advance care planning. Palliat Med 31(8):764–771

    Google Scholar 

  • Mack JW, Wolfe J, Grier HE, Cleary PD, Weeks JC (2006) Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. J Clin Oncol 24(33):5265–5270

    Article  PubMed  Google Scholar 

  • Mack JW, Cook EF, Wolfe J et al (2007) Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction. J Clin Oncol 25(11):1357–1362

    Article  PubMed  Google Scholar 

  • Mack JW, Wolfe J, Cook EF et al (2009) Peace of mind and sense of purpose as core existential issues among parents of children with cancer. Arch Pediatr Adolesc Med 163(6):519–524. https://doi.org/10.1001/archpediatrics

    Article  PubMed  Google Scholar 

  • MacLeod KD, Whitsett SF, Mash EJ et al (2003) Pediatric sibling donors of successful and unsuccessful hematopoietic stem cell transplants (HSCT): a qualitative study of their psychosocial experience. J Pediatr Psychol 28(4):223–231

    Article  PubMed  Google Scholar 

  • Mahmood LA, Casey D, Dolan JG, Dozier AM, Korones DN (2016) Feasibility of early palliative care consultation for children with high-risk malignancies. Pediatr Blood Cancer 63(8):1419–1422. https://doi.org/10.1002/pbc.26024

    Article  PubMed  Google Scholar 

  • Manne S, DuHamel K, Ostroff J et al (2004) Anxiety, depressive, and posttraumatic stress disorders among mothers of pediatric survivors of hematopoietic stem cell transplantation. Pediatrics 113:1700–1708

    Article  PubMed  Google Scholar 

  • Marks C, Stadler M, Häusermann P et al (2011) German–Austrian–Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD. Br J Dermatol 165(1):18–29

    Article  CAS  PubMed  Google Scholar 

  • Maude SL, Teachey DT, Porter DL, Grupp SA (2015) CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Blood 125(26):4017–4023. https://doi.org/10.1182/blood-2014-12-580068

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Meier JK-HH, Wolff D, Pavletic S et al (2011) Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Clin Oral Invest 15:127–139

    Article  Google Scholar 

  • Meyers CA, Weitzner M, Byrne K, Valentine A et al (1994) Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. J Clin Oncol 12:820–826

    Article  CAS  PubMed  Google Scholar 

  • Mohty M, Malard F, Abecassis M et al (2015) Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 50(6):781–789. https://doi.org/10.1038/bmt.2015.52

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nelson AS, Ashton LJ, Vajdic CM (2015) Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy. Leukemia 29(2):441–447. https://doi.org/10.1038/leu.2014.203

    Article  CAS  PubMed  Google Scholar 

  • Ness KK, Bhatia S, Baker KS et al (2005) Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study. Arch Pediatr Adolesc Med 159(8):706–713

    Article  PubMed  Google Scholar 

  • Packman W, Weber S, Wallace J, Bugescu N (2010) Psychological effects of hematopoietic SCT on pediatric patients, siblings and parents: a review. Bone Marrow Transplant 45:1134–1146

    Article  CAS  PubMed  Google Scholar 

  • Pession A, Masetti R, Rizzari C et al (2013) Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia. Blood 122(2):170–178. https://doi.org/10.1182/blood-2013-03-491621

    Article  CAS  PubMed  Google Scholar 

  • Petersen SL (2007) Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Dan Med Bull 54(2):112–139

    CAS  PubMed  Google Scholar 

  • Phipps S, Mulhern R (1995) Family cohesion and expressiveness promote resilience to the stress of pediatric bone marrow transplant: a preliminary report. J Dev Behav Pediatr 16:257–263

    Article  CAS  PubMed  Google Scholar 

  • Pillay B, Lee SJ, Katona L et al (2012) The psychosocial impact of haematopoietic SCT on sibling donors. Bone Marrow Transplant 47:1361–1365

    Article  CAS  PubMed  Google Scholar 

  • Pochon C, Oger E, Michel G et al (2015) Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react. Br J Haematol 169(2):249–261. https://doi.org/10.1111/bjh.13272

    Article  CAS  PubMed  Google Scholar 

  • Rettinger E, Merker M, Salzmann-Manrique E et al (2017) Pre-emptive immunotherapy for clearance of molecular disease in childhood acute lymphoblastic leukemia after transplantation. Biol Blood Marrow Transplant 23(1):87–95. https://doi.org/10.1016/j.bbmt.2016.10.006. Epub 2016 Oct 11

    Article  PubMed  Google Scholar 

  • Richardson PG, Riches ML, Kernan NA et al (2016) Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood 127(13):1656–1665. https://doi.org/10.1182/blood-2015-10-676924

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ringden O, Pavletic SZ, Anasetti C et al (2009) The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood 113(13):3110–3118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Roeland E, Mitchell W, Elia G et al (2010a) Symptom control in stem cell transplantation: a multidisciplinary palliative care team approach. Part 1: physical symptoms. J Support Oncol 8(3):100–116. Review

    CAS  PubMed  Google Scholar 

  • Roeland E, Mitchell W, Elia G et al (2010b) Symptom control in stem cell transplantation: a multidisciplinary palliative care team approach. Part 2: psychosocial concerns. J Support Oncol 8(4):179–183. Review

    PubMed  Google Scholar 

  • Siden H, Chavoshi N, Harvey B et al (2014) Characteristics of a pediatric hospice palliative are program over 15 years. Pediatrics 134(3):e765–e772. https://doi.org/10.1542/peds.2014-0381

    Article  PubMed  Google Scholar 

  • Slavin S, Nagler A, Naparstek E (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91(3):756–763

    CAS  PubMed  Google Scholar 

  • Stuber M, Nader K, Yasuda P (1991) Stress responses after pediatric bone marrow transplantation: preliminary results of a prospective longitudinal study. J Am Acad Child Adoles Psychiatr 30:952–957

    Article  CAS  Google Scholar 

  • Styczynski J, van der Velden W, Fox CP et al (2016) Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines. Sixth European Conference on Infections in Leukemia, a joint venture of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation (EBMT-IDWP), the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) Haematologica 101(7):803-811. doi: https://doi.org/10.3324/haematol.2016.144428. Review

  • Suttorp M, Claviez A, Bader P et al (2009) Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I. Klin Padiatr 221(6):351–357. https://doi.org/10.1055/s-0029-123952

    Article  CAS  PubMed  Google Scholar 

  • Svenberg P, Remberger M, Uzunel M et al (2016) Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation––a comparison of the last two decades. Pediatr Transplant 20(5):667–674. https://doi.org/10.1111/petr.12723

    Article  PubMed  Google Scholar 

  • Terrin N, Rodday AM, Tighiouart H et al (2013) Parental emotional functioning declines with occurrence of clinical complications in pediatric hematopoietic stem cell transplant. Support Care Cancer 21(3):687–695

    Article  PubMed  Google Scholar 

  • Ullrich CK, Dussel V, Hilden JM et al (2010) End-of-life experience of children undergoing stem cell transplantation for malignancy: parent and provider perspectives and patterns of care. Blood 115(19):3879–3885

    Article  CAS  PubMed  Google Scholar 

  • Ullrich CK, Rodday AM, Bingen K et al (2016a) Parent outlook: how parents view the road ahead as they embark on hematopoietic stem cell transplantation for their child. Biol Blood Marrow Transplant 22(1):104–111. https://doi.org/10.1016/j.bbmt.2015.08.040

    Article  PubMed  Google Scholar 

  • Ullrich CK, Lehmann L, London WB et al (2016b) End-of-life care patterns associated with pediatric palliative care among children who underwent hematopoietic stem cell transplant. Biol Blood Marrow Transplant 22(6):1049–1055. https://doi.org/10.1016/j.bbmt.2016.02.012

    Article  PubMed  PubMed Central  Google Scholar 

  • Vrijmoet-Wiersma CMJ, Egeler RM, Koopman HM et al (2009) Parental stress before, during, and after pediatric stem cell transplantation: a review article. Support Care Cancer 17:1435–1443. https://doi.org/10.1007/s00520-009-0685-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Weitz M, Strahm B, Meerpohl JJ (2015) Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients. Cochrane Database Syst Rev 12:CD009898. https://doi.org/10.1002/14651858.CD009898.pub3

    Google Scholar 

  • Wiener L, Baird K, Crum C et al (2014) Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study. Support Care Cancer 22(2):295–305

    Article  PubMed  PubMed Central  Google Scholar 

  • Wilhelmsson M, Vatanen A, Borgström B et al (2015) Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up. Bone Marrow Transplant 50(6):850–857. https://doi.org/10.1038/bmt.2015.43

    Article  CAS  PubMed  Google Scholar 

  • Wilkins KL, Woodgate RL (2007a) An interruption in family life: siblings’ lived experience as they transition through the pediatric bone marrow transplant trajectory. Oncol Nurs Forum 34:E28–E35

    Article  PubMed  Google Scholar 

  • Wilkins KL, Woodgate RL (2007b) Supporting siblings through the pediatric bone marrow transplant trajectory: perspectives of siblings of bone marrow transplant recipients. Cancer Nurs 30(5):E29–E34. https://doi.org/10.1097/01.NCC.0000290811.06948.2c

    Article  PubMed  Google Scholar 

  • Willard VW, Leung W, Huang Q et al (2014) Cognitive outcome after pediatric stem-cell transplantation: impact of age and Total-body irradiation. J Clin Oncol 32(35):3982–3989

    Article  PubMed  PubMed Central  Google Scholar 

  • Wolfe J, Klar N, Grier HE et al (2000) Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care. JAMA 284(19):2469–2475

    Article  CAS  PubMed  Google Scholar 

  • van der Zouwen B, Kruisselbrink AB, Jordanova ES et al (2012) Alloreactive effector T cells require the local formation of a proinflammatory environment to allow crosstalk and high avidity interaction with nonhematopoietic tissues to induce GVHD reactivity. Biol Blood Marrow Transplant 18(9):1353–1367. https://doi.org/10.1016/j.bbmt.2012.06.017

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Monika Führer .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Führer, M. (2018). Palliative Care in Hematopoietic Stem Cell Transplantation. In: Wolfe, J., Jones, B., Kreicbergs, U., Jankovic, M. (eds) Palliative Care in Pediatric Oncology. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-61391-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-61391-8_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-61390-1

  • Online ISBN: 978-3-319-61391-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics